Synergy between Vancomycin and Nafcillin against Staphylococcus aureus in an In Vitro Pharmacokinetic/Pharmacodynamic Model

INTRODUCTION: Continued pressure from glycopeptide use has led to non-susceptible strains of Staphylococcus aureus including heterogeneously vancomycin-intermediate S. aureus (hVISA). Infections with hVISA are associated with poor patient outcomes, thus incentivizing novel treatments. Evidence sugge...

Descripción completa

Detalles Bibliográficos
Autor principal: Leonard, Steven N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3404091/
https://www.ncbi.nlm.nih.gov/pubmed/22848719
http://dx.doi.org/10.1371/journal.pone.0042103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3404091/
https://www.ncbi.nlm.nih.gov/pubmed/22848719
http://dx.doi.org/10.1371/journal.pone.0042103

Ejemplares similares